Wayne State University

Running trials

• Not yet recruiting

  Can Mindfulness and Virtual Reality Reduce Stress in Young Adults With Type 1 Diabetes?

  NCT07793097· Source

• Active, not recruiting

  An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)

  NCT07517263· Phase 3· Source

• Recruiting

  Sacral Neuromodulation for Male Overactive Bladder (MOAB)

  NCT06511141· Source

• Recruiting

  Couples Motivational Interviewing to Reduce Drug Use and HIV Risk in Vulnerable Male Couples

  NCT06307977· Source

• Recruiting

  Asthma and Technology in Emerging African American Adults

  NCT05445583· Source

• Enrolling by invitation

  An Open-label Study of XEN1101 in Epilepsy

  NCT05718817· Phase 3· Source

• Recruiting

  A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures

  NCT05667142· Phase 3· Source

• Active, not recruiting

  Project 2: ACHIEVE- HF

  NCT05330221· Source

• Active, not recruiting

  Evaluating the InPen in Pediatric Type 1 Diabetes

  NCT05515939· Source

• Active, not recruiting

  Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis

  NCT05126277· Phase 3· Source

• Active, not recruiting

  Optimizing Detection and Prediction of Changes in Cognitive Function in Multiple Sclerosis (MS)

  NCT05252195· Source

• Recruiting

  Functional Brain Mapping for Patients with Epilepsy

  NCT05755919· Source

• Active, not recruiting

  A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple Sclerosis

  NCT05269004· Phase 3· Source

• Recruiting

  Investigating the Effect of Ocrelizumab in African Americans and Caucasians With Relapsing Multiple Sclerosis

  NCT04458688· Source

• Active, not recruiting

  A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis

  NCT04544449· Phase 3· Source

• Active, not recruiting

  Aspirin in Reducing Events in the Elderly-Extension (ASPREE-XT)

  NCT07224347· Source

• Recruiting

  A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)

  NCT03619850· Phase 3· Source

• Active, not recruiting

  Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis

  NCT01892722· Phase 3· Source

• Enrolling by invitation

  Clinical Phenotyping Resource and Biobank Core of the Michigan O'Brien Renal Center

  NCT01016613· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Epilepsy3 recruiting
• Asthma1 recruiting
• Chronic kidney disease1 recruiting
• Multiple sclerosis1 recruiting
• Prostate cancer1 recruiting
• Type 1 diabetes1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Terminated

  Efficacy and Safety of Perampanel in the Treatment of Refractory Status Epilepticus

  NCT05684978· Phase 4· Source

• Completed

  Longitudinal Studies to Identify Biomarkers for Sturge-Weber Syndrome

  NCT04717427· Source

• Completed

  Improving Outcomes for Patients With SDB and Insufficient Sleep

  NCT04279834· Source

• Completed

  Prospective Study to Assess Disease Activity and Biomarkers in Minority Participants With Relapsing Multiple Sclerosis (RMS) After Initiation and During Treatment With Ocrelizumab

  NCT04377555· Phase 4· Source

• Withdrawn

  Brain and Behavioral Influences on Motor Skill Learning in Multiple Sclerosis

  NCT03404388· Source

• Completed

  TRAIN-BW: Backward Walking Training in Multiple Sclerosis

  NCT04091464· Source

• Completed

  Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With CVD

  NCT04023552· Phase 3· Source

• Completed

  A Study To Investigate The Pharmacokinetics, Safety, And Tolerability Of Subcutaneous Ocrelizumab Administration In Participants With Multiple Sclerosis

  NCT03972306· Phase 1· Source

• Completed

  Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Trial

  NCT03500328· Source

• Completed

  Tryptophan Metabolism in Human Brain Tumors-Novocure

  NCT02367482· Source

• Recruiting

  Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort

  NCT01574053· Source